Medication info
Lipar 20 mg (Atorvastatin Calcium Hydrate)

Lipar 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
White round film-coated tablet
Packaging
[For domestic use] 30 tablets/bottle, 100 tablets/bottle [For export] 30T (10T/PTPX3)
Approval status
Active

MFDS item code 201500619 · Approved 2015.02.04 · Insurance code 671704510

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for those requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended to use LDL cholesterol to initiate treatment and assess response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.
Child dose
Ages 10 ~ 17: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hyperlipidemia
  • primary hypercholesterolemia
View approved original text

This medication helps reduce the risk of cardiovascular disease. It particularly reduces the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, for patients with existing heart disease, it lowers the risk of recurrent myocardial infarction, stroke, the need for vascular surgery, angina, and hospitalization for congestive heart failure. In hyperlipidemia patients, it effectively lowers total cholesterol and LDL cholesterol levels while raising HDL cholesterol levels. It is particularly used as an adjunct to dietary therapy for patients with familial hypercholesterolemia or dyslipidemia. It is also utilized to improve cholesterol levels in certain hypercholesterolemic pediatric patients. This medication is used for reducing the risk of cardiovascular disease and improving hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for those requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended to use LDL cholesterol to initiate treatment and assess response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in adult patients.

Child dose

Ages 10 ~ 17: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients).

Precautions

This medication may cause muscle-related symptoms; therefore, if severe muscle pain or weakness occurs or if creatine kinase levels rise significantly, the medication should be stopped immediately, and medical consultation is required. There is a risk of serious muscle diseases, such as myopathy or rhabdomyolysis, so caution is especially needed for patients with poor kidney function or liver disease. Patients with a history of allergic reactions to this medication, severely impaired liver functions, women who are pregnant or may become pregnant, children under the age of 10, and those taking specific medications should not take this medication. Patients with heavy alcohol use or a history of liver disease, elderly patients, and those with hypothyroidism should consult a doctor before taking this medication and closely monitor for muscle-related side effects. Regular liver function tests are recommended as liver function abnormalities may occur during treatment; if symptoms such as nausea, vomiting, or fatigue appear, medical attention should be sought immediately. Women planning to become pregnant while taking this medication must use appropriate contraception, and if pregnancy is confirmed, the medication should be discontinued. Additionally, this medication is not recommended for breastfeeding women, and it is safer to discontinue breastfeeding. Due to numerous drug interactions, especially with antibiotics, antifungals, HIV therapies, certain antihypertensives, oral contraceptives, grapefruit juice, etc., it is essential to consult a doctor or pharmacist when taking them together. In case of overdose, there is no specific antidote, so symptomatic treatment should be received and liver function and muscle enzyme levels should be monitored regularly. Keep this medication out of the reach of children, and store it in the original container to prevent misuse or quality deterioration.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 170 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste alteration
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rashes
  • itching
  • hair loss
  • angioedema
  • neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test values
  • gastritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • peptic duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • increased serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • increased urinary frequency
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • abnormal taste
  • taste distortion
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained, and degradation can be prevented.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

[For domestic use] 30 tablets/bottle, 100 tablets/bottle [For export] 30T (10T/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.